Epstein Secrets

& Venture Capaal Rep t Greenhill Secondary tslyvket Tftlroli 2015; arci ChYti Jorielt Private egtrty Analyst Guide Secondary Itarket. June 2017. Glendower Capital STRICTLY CONFIDENTIAL 31 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0099065 SDNY_GM_00245249 EFTA0139349

ity & Venture Capital Report. 2017 values as at June. (2) Source. Glendower Capital based on 2818 Preqin Gobal Pilate Eqt.Aly & Venture Capaal Rep t Greenhill Secondary tslyvket Tftlroli 2015; arci ChYti Jorielt Private egtrty Analyst Guide Secondary Itarket. June 2017. Glendower Capital STRICTLY CONFIDENTIA

itled to enforce any rights against the Underlying Fund or the Glendower GP or any of their affiliates, assert claims against the Underlying Fund, Glendower or their affiliates or have any voting rights in the Underlying Fund. An investor in the Access Fund will have only those rights provided for in th

arket pricing has recovered to within a transactable range, resulting in a more robust market. 57 Glendower Capital analysis and estimates based on Greenhill Secondary Market Trends & Outlook, January 2018; Cogent Partners Secondary Market Trends & Outlook, July 2014; Cogent Partners Secondary Market Update, March

itled to enforce any rights against the Underlying Fund or the Glendower GP or any of their affiliates, assert claims against the Underlying Fund, Glendower or their affiliates or have any voting rights in the Underlying Fund. An investor in the Access Fund will have only those rights provided for in th

arket pricing has recovered to within a transactable range, resulting in a more robust market. 57 Glendower Capital analysis and estimates based on Greenhill Secondary Market Trends & Outlook, January 2018; Cogent Partners Secondary Market Trends & Outlook, July 2014; Cogent Partners Secondary Market Update, March

itled to enforce any rights against the Underlying Fund or the Glendower GP or any of their affiliates, assert claims against the Underlying Fund, Glendower or their affiliates or have any voting rights in the Underlying Fund. An investor in the Access Fund will have only those rights provided for in th

arket pricing has recovered to within a transactable range, resulting in a more robust market. 57 Glendower Capital analysis and estimates based on Greenhill Secondary Market Trends & Outlook, January 2018; Cogent Partners Secondary Market Trends & Outlook, July 2014; Cogent Partners Secondary Market Update, March

itled to enforce any rights against the Underlying Fund or the Glendower GP or any of their affiliates, assert claims against the Underlying Fund, Glendower or their affiliates or have any voting rights in the Underlying Fund. An investor in the Access Fund will have only those rights provided for in th

arket pricing has recovered to within a transactable range, resulting in a more robust market. 57 Glendower Capital analysis and estimates based on Greenhill Secondary Market Trends & Outlook, January 2018; Cogent Partners Secondary Market Trends & Outlook, July 2014; Cogent Partners Secondary Market Update, March

itled to enforce any rights against the Underlying Fund or the Glendower GP or any of their affiliates, assert claims against the Underlying Fund, Glendower or their affiliates or have any voting rights in the Underlying Fund. An investor in the Access Fund will have only those rights provided for in th

arket pricing has recovered to within a transactable range, resulting in a more robust market. 57 Glendower Capital analysis and estimates based on Greenhill Secondary Market Trends & Outlook, January 2018; Cogent Partners Secondary Market Trends & Outlook, July 2014; Cogent Partners Secondary Market Update, March